documents: FDA-2011-D-0611-0065
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2011-D-0611-0065 | FDA | FDA-2011-D-0611 | New and Revised Draft Q&As on Biosimilar Development and the Biologics Price Competition and Innovation Act (Revision 2); Draft Guidance for Industry; Availability | Notice | Notice of Availability | 2018-12-12T05:00:00Z | 2018 | 12 | 2018-12-12T05:00:00Z | 2019-02-12T04:59:59Z | 2019-11-18T16:51:35Z | 2018-26852 | 0 | 0 | 0900006483987c81 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref